share_log

Cantor Fitzgerald Downgrades Aravive to Neutral, Lowers Price Target to $0.25

Benzinga ·  Aug 22, 2023 07:56

Cantor Fitzgerald analyst Louise Chen downgrades Aravive (NASDAQ:ARAV) from Overweight to Neutral and lowers the price target from $18 to $0.25.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment